Mac-2 Binding Protein Glycosylation Isomer as a Hepatocellular Carcinoma Marker in Patients With Chronic Hepatitis B or C Infection-Reference-Cited by-同舟云学术

Mac-2 Binding Protein Glycosylation Isomer as a Hepatocellular Carcinoma Marker in Patients With Chronic Hepatitis B or C Infection

Published:2019-02-08 Issue:4 Volume:3 Page:493-503
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatol Commun

Author:

Jun Tomi¹^ORCID,Hsu Yao-Chun²³⁴⁵,Ogawa Shintaro⁶,Huang Yen-Tsung⁷,Yeh Ming-Lun⁸,Tseng Cheng-Hao⁴,Huang Chung-Feng⁸,Tai Chi-Ming⁵,Dai Chia-Yen⁸,Huang Jee-Fu⁸,Chuang Wan-Long⁸,Yu Ming-Lung⁸^ORCID,Tanaka Yasuhito⁶,Nguyen Mindie H.⁹

Affiliation:

1. Department of Medicine; Stanford University Medical Center; Palo Alto CA

2. Division of Gastroenterology and Hepatology; Fu Jen Catholic University Hospital; New Taipei Taiwan

3. School of Medicine; Fu Jen Catholic University; New Taipei Taiwan

4. Division of Gastroenterology and Hepatology; E-Da Hospital; Kaohsiung Taiwan

5. Graduate Institute of Clinical Medical Science; China Medical University; Taichung Taiwan

6. Department of Virology and Liver Unit; Nagoya City University Graduate School of Medical Sciences; Nagoya Japan

7. Institute of Statistical Science; Academia Sinica; Taipei Taiwan

8. Hepatobiliary Division, Department of Internal Medicine; Kaohsiung Medical University Hospital, Kaohsiung Medical University; Kaohsiung Taiwan

9. Division of Gastroenterology and Hepatology; Stanford University Medical Center; Palo Alto CA

Publisher

Wiley

Subject

General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep4.1321/fullpdf

Reference39 articles.

1. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the Global Burden of Disease Study;Fitzmaurice;JAMA Oncol,2017

2. Update on biomarkers of hepatocellular carcinoma;Chaiteerakij;Clin Gastroenterol Hepatol,2015

3. A serum “sweet-doughnut” protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis;Kuno;Sci Rep,2013

4. A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA(+)-M2BP), for assessing liver fibrosis;Toshima;J Gastroenterol,2015

5. Serum WFA+ -M2BP levels for evaluation of early stages of liver fibrosis in patients with chronic hepatitis B virus infection;Zou;Liver Int,2017

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disease modifiers and novel markers in HBV-related HCC;Journal of Liver Cancer;2024-08-05

2. Mac-2 binding protein glycosylation isomer as a novel predictor of early recurrence after resection for hepatocellular carcinoma;Surgery Today;2024-06-28

3. SUV39H1 is a novel biomarker targeting oxidative phosphorylation in hepatitis B virus-associated hepatocellular carcinoma;BMC Cancer;2023-11-28

4. Prediction and surveillance of de novo HCC in patients with compensated advanced chronic liver disease after hepatitis C virus eradication with direct antiviral agents;Frontiers in Virology;2023-10-24

5. Noninvasive assessments of liver disease severity based on biomarkers;Comprehensive Guide to Hepatitis Advances;2023